Taro Pharmaceuticals to pay $419 million to resolve US DOJ price-fixing allegations over generic drugs
Taro Pharmaceuticals agreed to pay nearly $419 million and admit to participating in two conspiracies to fix prices, allocate customers and hike prices of generic drugs in order to resolve criminal...To view the full article, register now.
Already a subscriber? Click here to view full article